28Mar 2021
Immune checkpoint inhibitor-related pneumonitis in lung cancer: real-world incidence, risk factors, and management practices across six health care centers in North Carolina

Immune checkpoint inhibitor-related pneumonitis in lung cancer: real-world incidence, risk factors, and management practices across six health care centers in North Carolina

In this cohort, ICI-P was more common and severe than previously reported and carried an unexpectedly high mortality rate. Risk for ICI-P appears independently associated with several chronic pulmonary diseases, which may account for the higher incidence of ICI-P in lung cancer patients.

  • #pulmonology

Like

Save

Share